Andrew D Dickinson
CFO at Gilead Sciences, Inc. (GILD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $145.29 | $436K | -0.5% |
| Aug 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $138.36 | $415K | +4.5% |
| Jul 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $129.93 | $390K | +11.3% |
| Jun 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $125.40 | $376K | +15.3% |
| May 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $132.27 | $397K | +9.3% |
| Apr 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $140.96 | $423K | +2.6% |
| Mar 17SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $144.23 | $433K | +0.3% |
| Feb 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $154.43 | $463K | -6.3% |
| Jan 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $124.31 | $373K | +16.3% |
| Dec 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 3,000 | $122.00 | $366K | +18.5% |
| Nov 18SEC | GILDGilead Sciences, Inc. | Sell Plan | 2,500 | $125.23 | $313K | +15.5% |
| Oct 16SEC | GILDGilead Sciences, Inc. | Sell Plan | 2,500 | $118.08 | $295K | +22.5% |
- Sell
CFO Andrew D Dickinson sold $436K of GILD at $145.29 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $415K of GILD at $138.36 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $390K of GILD at $129.93 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $376K of GILD at $125.40 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $397K of GILD at $132.27 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Andrew D Dickinson sold $423K of GILD at $140.96 — pre-scheduled 10b5-1 plan sale.